A detailed history of American Portfolios Advisors transactions in Natera, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 420 shares of NTRA stock, worth $64,436. This represents 0.0% of its overall portfolio holdings.

Number of Shares
420
Holding current value
$64,436
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023

BUY
$36.93 - $56.68 $15,510 - $23,805
420 New
420 $18.4 Million
Q1 2022

Mar 21, 2023

BUY
$30.32 - $91.33 $10,612 - $31,965
350 Added 83.33%
770 $31.3 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $14.9B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.